The proposed bill aims to improve diabetes management in Florida by establishing a comprehensive support and coverage framework for diabetes care. It mandates the Department of Health to create a website that provides information and facilitates referrals to federally qualified health centers, which must make a good faith effort to schedule appointments within 30 days of receiving referrals. Additionally, the bill allows pharmacists to prescribe and dispense a 30-day supply of insulin and other diabetes-related medications under specific conditions, ensuring that patients are charged no more than their insurance copayment or the usual cost if uninsured.

The legislation introduces new provisions that cap cost-sharing requirements for diabetes-related medications and devices, limiting patient expenses to $35 for a 30-day supply of insulin or glucagon drugs and $100 for diabetes devices. It also modifies the prescription drug monitoring program by requiring dispensers to report all insulin drugs, glucagon drugs, diabetes devices, and diabetic ketoacidosis devices to the system, while clarifying access rights for program managers and support staff to non-identifying patient information. The act is set to take effect on July 1, 2025, and will apply to all health maintenance contracts delivered, issued, renewed, or amended on or after January 1, 2026.